I. Project Background

Benefit Pharmaceuticals was established in 2007. The group comprises four core strategic sectors: pharmaceutical commerce, modern Chinese medicine production, green agriculture (Chinese herbal medicine) cultivation, and Chinese medical health industry. These are represented by Benefit Pharmaceutical Commerce Co., Ltd., Benefit Pharmaceutical Co., Ltd., Yilv Agricultural Technology Co., Ltd., and Chuzhou Traditional Chinese Medicine Hall. This structure forms an integrated Chinese medicine ecological industry chain encompassing cultivation, research, production, sales, and medical wellness. It aims to build a comprehensive health industry ecosystem spanning the entire life cycle, positioning itself as a national high-tech modern pharmaceutical enterprise. To further enrich the product line and meet market demand for high-quality health products, the company has decided to enter the health supplement sector and develop a Hericium Erinaceus Solid Beverage.

Hericium Erinaceus, one of China's eight "mountain treasures," is a culinary delicacy and a valuable Chinese medicinal herb. Neutral in nature and sweet in taste, it benefits the five internal organs and harmonizes stomach qi. With its dual use as medicine and food, it is an excellent product for nourishing the stomach, possessing functions such as tonifying the body, aiding digestion, and benefiting the internal organs. Modern research indicates that Hericium Erinaceus contains active ingredients like peptides, polysaccharides, fats, and proteins, which have therapeutic effects on digestive tract tumors, gastric and duodenal ulcers, gastritis, bloating, etc. Benefit Pharmaceuticals has developed a Hericium Erinaceus Solid Beverage using this ingredient. It offers convenient consumption and nourishes the stomach. Benefit's Hericium Erinaceus Solid Beverage utilizes Hericium Erinaceus cultivated in a sterile, weak-acid environment, ensuring robust growth, cleanliness, and rich nutrition, providing the human body with essential amino acids, polysaccharides, and peptides. This product is also fortified with various vitamins and minerals, characterized by fast digestion and good absorption.

To better enhance the brand image and convey Benefit Pharmaceuticals' pursuit of health and quality to more consumers, we now publicly solicit trademark names and logo designs for this product. We look forward to your creativity and inspiration!

II. Product Summary

Product Name: Hericium Erinaceus Solid Beverage

Product Positioning: Delicious, Nutritious, Nourishing the Stomach

III. Target Participants

Professional designers, creative enthusiasts, advertising agencies, design studios, etc. Individuals and organizations from all fields are welcome to participate actively.

IV. Submission Requirements

1. The concept must be distinct and align with the product positioning.

2. Incorporate Benefit Pharmaceuticals' value mission of "Extracting the Essence of Chinese Medicine, Promoting Traditional Culture" and its enduring pursuit of health and quality, effectively reflecting the cultural connotation of Benefit Pharmaceuticals.

3. The composition should be novel, with an overall visual effect that is grand, simple, eye-catching, possessing strong visual impact and aesthetic appeal, and easy to identify, remember, and promote.

4. Design works must be original creations, demonstrating broad applicability, and suitable for production on various carriers and dissemination across electronic media.

5. Electronic submissions must have a resolution no lower than 300dpi (pixels/inch), with dimensions no smaller than 1000*1000 pixels, in JPG or TIF format. If selected, a complete vector file (AI or CDR format) must be provided, along with a creative description (Word document, within 500 words) briefly explaining the concept and meaning of the work.

6. Submitted works must not violate relevant laws and regulations such as the "Trademark Law of the People's Republic of China" and the "Copyright Law of the People's Republic of China" in content or form. They must comply with requirements for social order and good customs, and must not involve religion, pornography, violence, or sensitive international and political issues.

V. Submission Period

From now until February 20, 2025.

VI. Selection Method and Awards

1. This activity will ultimately select 1 winning work and 2 outstanding works.

2. The winning work will receive a reward of ¥5,000, and each outstanding work will receive ¥2,000. All participants will receive a gift provided by Benefit Pharmaceuticals.

VII. Important Notes

1. Clearly indicate the designer's name, contact information, and address in the bottom right corner.

2. Submitted works must be original creations owned by the submitter, never published in any form before, and must not be identical or similar to any already registered or preliminarily approved trademarks. The works must be free of intellectual property disputes and must not infringe upon others' intellectual property rights. The submitter (author) shall bear all consequences arising from intellectual property disputes, infringement, or any unreasonable reasons related to the work. If Benefit Pharmaceuticals' rights are infringed, negative impacts occur, or losses are incurred, Benefit Pharmaceuticals reserves the permanent right to claim compensation.

3. Upon submission, the submitter (author) is deemed to agree to all contents of this announcement and its attachments, and Benefit Pharmaceuticals' interpretation of this solicitation. The submitter (author) shall strictly fulfill obligations of legality, compliance, confidentiality, and integrity. Concurrently, the submitter shall not use the submitted work for trademark, patent, or copyright registration, nor transfer or authorize the work to others, nor use the work to participate in other activities. The submitter agrees to participate in this trademark and logo design solicitation activity according to Benefit Pharmaceuticals' requirements.

4. Submitted works will not be returned. The submitter confirms and agrees to Benefit Pharmaceuticals' method of evaluating submissions. Once a work is shortlisted, Benefit Pharmaceuticals will inquire and verify whether the shortlisted work can be used for trademark registration. Without written consent from Benefit Pharmaceuticals, the submitter (author) shall not publicly disclose or exercise any rights over the work.

5. Once a work is adopted, the submitter (author) voluntarily relinquishes all rights related to the work and agrees that the intellectual property rights of the work belong solely to Benefit Pharmaceuticals. Benefit Pharmaceuticals shall have the right to freely use, modify, and dispose of the work.

6. For identical or similar submitted works, priority for shortlisting will be given based on the order of submission time. If disputes or losses to others arise due to rights defects, false, illegal, improper content, or any unreasonable reasons related to the submitted work, it has no relation to the activity or the organizer. The submitter shall bear all consequences.

7. This solicitation activity is free of charge. Submitters (authors) voluntarily accept the constraints of this announcement. Benefit Pharmaceuticals reserves the final right of interpretation for this activity.

VIII. Submission Methods

1. Email Submission:

bnft_107@163.com

File name: "Author Name (Organization) + Design Proposal". Email subject: "Benefit Pharmaceuticals Hericium Erinaceus Solid Beverage Trademark and LOGO Solicitation".

2. Postal Submission: No. 90, Yunjing Road, Liandu District, Lishui City, Zhejiang Province.

Contact: Mr. Wang

Contact Phone: +86 15355585110